Peripheral Artery

  • 3E05 Peripheral Artery
    • 3E050 Open
      • 3E0500 Antineoplastic
        • 3E05002 Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach
        • 3E05003 Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach
        • 3E05005 Introduction of Other Antineoplastic into Peripheral Artery, Open Approach
        • 3E0500M Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach
        • 3E0500P Introduction of Clofarabine into Peripheral Artery, Open Approach
      • 3E0501 Thrombolytic
        • 3E05016 Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Open
        • 3E05017 Introduction of Other Thrombolytic into Peripheral Artery, Open Approach
      • 3E0502 Anti-infective
        • 3E05028 Introduction of Oxazolidinones into Peripheral Artery, Open Approach
        • 3E05029 Introduction of Other Anti-infective into Peripheral Artery, Open Approach
      • 3E0503 Anti-inflammatory
        • 3E0503Z Introduction of Anti-inflammatory into Peripheral Artery, Open Approach
      • 3E0504 Serum, Toxoid and Vaccine
        • 3E0504Z Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Open Approach
      • 3E0506 Nutritional Substance
        • 3E0506Z Introduction of Nutritional Substance into Peripheral Artery, Open Approach
      • 3E0507 Electrolytic and Water Balance Substance
        • 3E0507Z Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Open Approach
      • 3E050F Intracirculatory Anesthetic
        • 3E050FZ Introduction of Intracirculatory Anesthetic into Peripheral Artery, Open Approach
      • 3E050G Other Therapeutic Substance
        • 3E050GC Introduction of Other Therapeutic Substance into Peripheral Artery, Open Approach
        • 3E050GN Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Open Approach
      • 3E050H Radioactive Substance
        • 3E050HZ Introduction of Radioactive Substance into Peripheral Artery, Open Approach
      • 3E050K Other Diagnostic Substance
        • 3E050KZ Introduction of Other Diagnostic Substance into Peripheral Artery, Open Approach
      • 3E050N Analgesics, Hypnotics, Sedatives
        • 3E050NZ Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Open Approach
      • 3E050P Platelet Inhibitor
        • 3E050PZ Introduction of Platelet Inhibitor into Peripheral Artery, Open Approach
      • 3E050R Antiarrhythmic
        • 3E050RZ Introduction of Antiarrhythmic into Peripheral Artery, Open Approach
      • 3E050T Destructive Agent
        • 3E050TZ Introduction of Destructive Agent into Peripheral Artery, Open Approach
      • 3E050V Hormone
        • 3E050VG Introduction of Insulin into Peripheral Artery, Open Approach
        • 3E050VH Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach
        • 3E050VJ Introduction of Other Hormone into Peripheral Artery, Open Approach
      • 3E050W Immunotherapeutic
        • 3E050WK Introduction of Immunostimulator into Peripheral Artery, Open
        • 3E050WL Introduction of Immunosuppressive into Peripheral Artery, Open
      • 3E050X Vasopressor
        • 3E050XZ Introduction of Vasopressor into Peripheral Artery, Open Approach
    • 3E053 Percutaneous
      • 3E0530 Antineoplastic
        • 3E05302 Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach
        • 3E05303 Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach
        • 3E05305 Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach
        • 3E0530M Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach
        • 3E0530P Introduction of Clofarabine into Peripheral Artery, Percutaneous Approach
      • 3E0531 Thrombolytic
        • 3E05316 Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous
        • 3E05317 Introduction of Other Thrombolytic into Peripheral Artery, Percutaneous Approach
      • 3E0532 Anti-infective
        • 3E05328 Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach
        • 3E05329 Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach
      • 3E0533 Anti-inflammatory
        • 3E0533Z Introduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approach
      • 3E0534 Serum, Toxoid and Vaccine
        • 3E0534Z Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Percutaneous Approach
      • 3E0536 Nutritional Substance
        • 3E0536Z Introduction of Nutritional Substance into Peripheral Artery, Percutaneous Approach
      • 3E0537 Electrolytic and Water Balance Substance
        • 3E0537Z Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Percutaneous Approach
      • 3E053F Intracirculatory Anesthetic
        • 3E053FZ Introduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approach
      • 3E053G Other Therapeutic Substance
        • 3E053GC Introduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach
        • 3E053GN Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Percutaneous Approach
      • 3E053H Radioactive Substance
        • 3E053HZ Introduction of Radioactive Substance into Peripheral Artery, Percutaneous Approach
      • 3E053K Other Diagnostic Substance
        • 3E053KZ Introduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach
      • 3E053N Analgesics, Hypnotics, Sedatives
        • 3E053NZ Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Percutaneous Approach
      • 3E053P Platelet Inhibitor
        • 3E053PZ Introduction of Platelet Inhibitor into Peripheral Artery, Percutaneous Approach
      • 3E053R Antiarrhythmic
        • 3E053RZ Introduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approach
      • 3E053T Destructive Agent
        • 3E053TZ Introduction of Destructive Agent into Peripheral Artery, Percutaneous Approach
      • 3E053V Hormone
        • 3E053VG Introduction of Insulin into Peripheral Artery, Percutaneous Approach
        • 3E053VH Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach
        • 3E053VJ Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach
      • 3E053W Immunotherapeutic
        • 3E053WK Introduction of Immunostimulator into Peripheral Artery, Percutaneous
        • 3E053WL Introduction of Immunosuppressive into Peripheral Artery, Percutaneous
      • 3E053X Vasopressor
        • 3E053XZ Introduction of Vasopressor into Peripheral Artery, Percutaneous Approach